Home > News

Follow Us

Oxidized LDL, a novel marker in Alzheimer´s disease research

Increased plasma levels of oxidized LDL and TNF-alpha were observed in Alzheimer´s disease patients compared to age matched control subjects.

In addition, individual plasma levels of oxidized LDL were shown to be positively correlated to the percentage of TNF-alpha, PARP-1, presenilin-1 or CR38 positive cells. These findings may indicate an activation process of peripheral blood mononuclear cells by oxLDL, consistent with previous studies showing an inducation of apoptosis and inflammation by oxLDL in monocytes / macrophages as well as neurons and the production of cytokines like TNF-alpha.

Please download the publication by Kassner et.al to read more about correlation between oxidized LDL and Alzheimer´s disease

 

05/05/14 Combining two technologies may increase the effectiveness of oral insulin

04/10/14 Supplemental diets for cows benefit their performance

04/01/14 Mercodia announces collaboration with Chongqing Zhongyuan Biotechnology Co in China

03/20/14 Blocking Ca-ion flow alleviates hypoxia-induced damage to beta cells

03/10/14 NEW – Mercodia Launches Rat Glicentin ELISA

02/27/14 Glucagon WEBINAR with Professor Jens Juul Holst

More news and archive | Return | Print